Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Feb 14 2022

Full Issue

Effectiveness Of Pfizer Booster Drops After 4 Months But Still Protects Well

Its protection against hospitalization fell from 91% at two months to 78% by the fourth month, a study found. In related news, the CDC now recommends that immunocompromised Americans get a booster three months after the initial series of the Pfizer-BioNTech or Moderna shots, rather than the current five months.

CNN: Covid-19 Vaccine Booster Effectiveness Wanes After Four Months But Still Offers Protection, Study Finds 

Booster doses of the Pfizer/BioNTech and Moderna coronavirus vaccines are safe, and they offer high levels of protection against severe Covid-19 even though that protection can wane over time, according to two studies published by the US Centers for Disease Control and Prevention on Friday. Evidence of waning protection "reinforces the importance of further consideration of additional doses to sustain or improve protection" against Covid-19-linked hospitalizations and emergency department visits, one of the studies says. (Howard, 2/13)

AP: Study: COVID Booster Effectiveness Wanes But Remains Strong 

An early look at the performance of COVID-19 booster shots during the recent omicron wave in the U.S. hinted at a decline in effectiveness, though the shots still offered strong protection against severe illness. The report, published by the Centers for Disease Control and Prevention on Friday, is considered an early and limited look at the durability of booster protection during the omicron surge that exploded in December and January but has been fading in recent weeks. (Stobbe, 2/11)

But immunocompromised people can get a booster sooner —

The Washington Post: CDC Recommends People With Weakened Immune Systems Get Booster Doses After Three Months Instead Of Five 

The Centers for Disease Control and Prevention updated its guidance on Friday for some people with weakened immune systems, recommending they get a booster dose of the coronavirus vaccine three months after completing the initial series of the Pfizer-BioNTech or Moderna shots, rather than the current interval of five months. The guidance also said immunocompromised people who received the one-shot Johnson & Johnson vaccine should get an additional dose. That means two doses, at least 28 days apart, followed by a booster dose of one of the mRNA vaccines. (Sun, 2/11)

In other news about the vaccine rollout —

The Denver Channel: Many Fully Vaccinated Americans Are Saying No To The Booster

Across the country, states are loosening COVID-19 restrictions even though the federal government and the Centers for Disease Control continue to say masks should still be worn inside public spaces. So how close are we to the end of the health crisis and why are some public health experts warning of a looming booster shot problem? (St. George, 2/14)

Bay Area News Group: COVID Vaccine Hesitancy Remains In Bay Area’s Black, Latino Families

Thousands of Bay Area school kids still don’t have their COVID-19 shots despite looming school vaccine mandates, provoking uncertainty among school leaders and fear in parents about how the requirements could impact long- and short-term learning for unvaccinated students. Despite efforts to boost vaccination numbers across the region since last fall, Black and Latino teens ages 12 and up remain less likely to be vaccinated for the virus than their White and Asian classmates, a Bay Area News Group analysis of data from local school districts and public health departments found. (Jimenez and Rowan, 2/13)

Stat: Why Covid-19 Vaccines Are A Freaking Miracle 

Two years into the Covid-19 pandemic, it’s easy to lament all that has come to pass. The devastating losses. The upending of what we regarded as normal ways of life. The sheer relentlessness of it all. But let’s stop for a moment and consider something else that may have escaped you: You have witnessed — and you are a beneficiary of — a freaking miracle. That miracle is the development, testing, manufacturing, and global distribution of Covid vaccines. (Branswell, 2/14)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF